Evozyne has announced the closing of an $81 million series B investment round that will fund the biotech's generative AI-powered drug discovery platform and product development.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,